Fungal Staining Reagent Market Overview
According to the latest research by Future Market Insights, Fungal Staining Reagent market is set to experience growth during the year 2021-2031. Fungal stains continue to be an important tool in the diagnostic staging of tissue laboratories for characterizing infectious microorganisms.
Dermatophytes, or superficial fungal infections involving the skin, rarely pose serious health problems for men. However, systemic fungal infections caused by microorganisms such as Cryptococcusneoformans and Candidaalbicans can cause life-threatening infections, especially in immunocompromised people.
It is important to consider the fungal disease in relation to the 2019 pandemic of coronavirus infection (COVID19) because the symptoms of some fungal disease May be similar to those of COVID19, including fever, cough and shortness of breath. Clinical tests are needed to determine whether a person has a fungal infection or COVID19 to provide adequate treatment.
Get a Sample PDF Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13707
What is driving Demand for Fungal Staining Reagent?
Fungal infections are common in people infected with HIV/AIDS, organ transplant patients, cancer patients, hospitalized patients, stem cell transplant patients and people with weakened immune system. Therefore, when signs of fungal infection are observed on H&E staining, fungal stains are often urgently ordered by a surgical pathologist. Schiff’s reagent and hexamine silver solution stain. Grocott’s Silver (GMS) staining is perhaps the most widely used fungal stain.
Some pathologists order acid Schiff (PAS) staining regularly, expecting to achieve faster and more reliable staining. This method is one of the most frequently used methods in tissue laboratories. Relatively simple and reliable to run even with inexperienced hands. Increasing prevalence of fungal infections propel the growth of fungal staining reagent market.
Increasing Incidence of Fungal Diseases Likely to Augment Fungal Staining Reagent Sales
People with severe COVID-19 who seem to be in an intensive care unit (ICU) are particularly vulnerable to bacterial or fungal infections. Co-infection with these fungi is increasing in frequency, reported, and can be associated with serious illness and death.
Awareness of the potential for co-infection with fungi is essential to reduce delays in diagnosis and treatment in order to prevent serious illness and death from these infections. Thus, rise in incidence of Fungal Diseases is expected to boost the demand for Fungal Staining Reagent.
Ask to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-13707
Europe Demand Outlook for Fungal Staining Reagent
There are concerns about an increase in Candida auris infection, a fungus that is difficult to control in Europe. Fungi can easily spread in the medical environment and cause invasive infections, and my achievements for several types of antifungal agents are also relevant. Due to the difficulty of identifying the laboratory and the lack of recognition of this new Candida species, radio waves and onset can remain unobtrusive.
Some of the key players operating in the Fungal Staining Reagent market are
- Teco Diagnostic
- Biocare Corporation
- I-SENS, Inc.
- VivaChek Laboratories Inc.
- Vmed Technology
- SunTech Medical Inc.
- IDEXX Laboratories Inc.
- Zoetis Inc.
- Merck KGaA
- Darmstadt
- HiMedia Laboratories
Buy this Report Now: https://www.futuremarketinsights.com/checkout/13707
Key Segments Covered:
By Test Type:
- KOH Prep (Potassium Hydroxide Solution)
- Calcofluor White Stain
By Reagent Type:
- Congo Red
- Gomori Methenamine Silver Stain
- Mucicarmine Stain
- Periodic Acid Schiff (Pas) Stain
- Sulfation Reagent And Toludine Blue O (Tbo)
- Modified Ziehl-Neelsen Stain
- Acridine Orange
- Phol Stain
- Lactophenol Blue Stain
By End Use:
- Diagnostic Centres
- Hospitals
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa
Explore Top Reports from Healthcare Market:
https://www.youthkiawaaz.com/2022/09/organ-preservation-market-to-show-cagr-of-6-4
About FMI:
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!
Contact Us:
Future Market Insights,
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs